Strategic Partnership

PEACCEL establishes strategic partnerships with key players in the chemical industry, with biotech and pharma companies in addition to start-ups with complementary advantages or cutting edge innovation.

Latest News

News

Accurate modeling of metabolic pathways for drug target identification and…

25 July 2022

PEACCEL and partners underline in the June 2022 issue of…

News

PEACCEL co-authored a critical review on VHH structural modelling approaches…

18 July 2022

VHH, i.e., VH domains of camelid single-chain antibodies, are very…

News

PEACCEL and SYNTHELIS have signed a strategic partnership to increase…

12 May 2022

PEACCEL and SYNTHELIS have signed a strategic partnership to offer…